Global X ETFs Genomics & Biotechnology UCITS ETF USD Acc (GNOG)
£0.17
(3.01%)
- Add to watchlist
- Create an alert
- This stock can be held in a
£0.17
(3.01%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
£0.17
(3.01%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
£5.54
£5.66
£7.02
London
£5.51
£5.54
£5.37
$17.69M
£0.05 (0.99%) Previous:
£0.05
6,042
n/a
GBP
ETP Basics
| Issuer: | Global X ETFs ICAV |
|---|---|
| Structure: | ETF |
| Replication method: | Stocks - Full Replication |
| Securities lending: | No |
| Number of holdings: | 41 |
| Size: | $17.7M |
| Launch date: | 11 February 2021 |
| Launch price: | n/a |
| UCITS: | Yes |
| Reporting status: | Yes |
| Domicile: | Ireland |
| Complex product: | Non-complex |
| ISIN: | IE00BM8R0N95 |
Annual & interim reports
Before you invest, please make sure you read the documents below
Ready to invest?
Important Documents
There are no documents available for this stock.
OBJECTIVE
| Index: | The Global X Genomics & Biotechnology UCITS ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics v2 Index. |
|---|---|
| Aim: |
The Global X Genomics & Biotechnology UCITS ETF (GNOM LN) seeks to provide investment...
Read full aim for Global X ETFs |
| Leverage: | 100% |
| Currency hedging: | n/a |
COSTS
| Ongoing Charge (OCF/TER): | 0.50% |
|---|---|
| Management fee: | 0.50% |
| Indicative spread: | 0.6% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Performance
| 1 week 1W | 3.37% | 1 year 1Y | 3.96% |
|---|---|---|---|
| 1 month 1M | 2.57% | 2 years 2Y | 25.13% |
| 3 months 3M | 8.29% | 3 years 3Y | 49.46% |
| 6 months 6M | 6.16% | 5 years 5Y | n/a |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
| Security | Weight |
|---|---|
| TAKARA BIO | 52.95% |
| GENSCRIPT BIOTECH CORP | 11.69% |
| 10X GENOMICS INC | 2.86% |
| NATERA INC | 1.94% |
| SAREPTA THERAPEUTICS | 1.82% |
| QIAGEN N.V. | 1.66% |
| BIOMARIN PHARMACEUTICAL | 1.59% |
| AGILENT TECHNOLOGIES INC | 1.57% |
| BIO-TECHNE CORPORATION | 1.55% |
| BIONTECH SE | 1.54% |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.